Next Article in Journal
Investigating the Influence of Magnesium Ions on p53–DNA Binding Using Atomic Force Microscopy
Next Article in Special Issue
Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms
Previous Article in Journal
Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
Previous Article in Special Issue
The Role of HCG in Implantation: A Mini-Review of Molecular and Clinical Evidence

Human Chorionic Gonadotropin and Breast Cancer

Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany
Author to whom correspondence should be addressed.
Academic Editor: Udo Jeschke
Int. J. Mol. Sci. 2017, 18(7), 1587;
Received: 13 March 2017 / Revised: 17 July 2017 / Accepted: 17 July 2017 / Published: 21 July 2017
(This article belongs to the Special Issue hCG—An Endocrine, Regulator of Gestation and Cancer)
Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy. View Full-Text
Keywords: human chorionic gonadotropin; pregnancy; breast cancer human chorionic gonadotropin; pregnancy; breast cancer
MDPI and ACS Style

Schüler-Toprak, S.; Treeck, O.; Ortmann, O. Human Chorionic Gonadotropin and Breast Cancer. Int. J. Mol. Sci. 2017, 18, 1587.

AMA Style

Schüler-Toprak S, Treeck O, Ortmann O. Human Chorionic Gonadotropin and Breast Cancer. International Journal of Molecular Sciences. 2017; 18(7):1587.

Chicago/Turabian Style

Schüler-Toprak, Susanne, Oliver Treeck, and Olaf Ortmann. 2017. "Human Chorionic Gonadotropin and Breast Cancer" International Journal of Molecular Sciences 18, no. 7: 1587.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop